NCT02475564View on ClinicalTrials.gov

Resveratrol for Pain Due to Endometriosis

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Endometriosis
Interventions
DRUG

Placebo

40mg of starch

DRUG

Resveratrol

40mg of resveratrol (powder)

Trial Locations (1)

90035-903

HCPA, Porto Alegre

All Listed Sponsors
lead

Hospital de Clinicas de Porto Alegre

OTHER

NCT02475564 - Resveratrol for Pain Due to Endometriosis | Biotech Hunter | Biotech Hunter